<DOC>
	<DOCNO>NCT02080104</DOCNO>
	<brief_summary>Intramuscular versus intravenous prophylactic oxytocin third stage labour follow vaginal delivery : A randomised control trial</brief_summary>
	<brief_title>Intramuscular Versus Intravenous Prophylactic Oxytocin Hemorrhage After Vaginal Delivery</brief_title>
	<detailed_description>Prevention postpartum haemorrhage essential pursuit improve health care woman . In study investigator aim compare intramuscular oxytocin intravenous oxytocin routine prevention postpartum haemorrhage woman deliver vaginally.In country , intravenous access provide easily . Intramuscular application faster , easy tougher enforcement require less skill equipment . For reason , less educate , applied offering health service .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Postpartum Hemorrhage</mesh_term>
	<mesh_term>Oxytocin</mesh_term>
	<criteria>1 . Research volunteer , undersigned , pregnant woman 2 . Only vaginal delivery ( episiotomy perineal tear ) 3 . &gt; 34 week 4 . Cephalic presentation 5 . At low risk postpartum hemorrhage 1 . &lt; 18 year 2 . Multiple pregnancy 3 . The presence uterine myoma 4 . Having postpartum hemorrhage previous pregnancy 5 . Placenta previa , polyhydramnios 6 . More four parity 7 . Fetal macrosomia 8 . Hb &lt; 9mg/dl 9. preeclampsia 10 . Uterine anomaly 11 . Receiving anticoagulant therapy , suspect coagulopathy 12 . &gt; 42 week pregnancy 13 . Oxytocin allergy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>postpartum hemorrhage</keyword>
	<keyword>oxytocin</keyword>
	<keyword>vaginal delivery</keyword>
	<keyword>prophylactic</keyword>
</DOC>